111130-13-3

111130-13-3 structure

Name: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt
Chemical Name: sodium,N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-2-methylphenyl]-1,2,3-triaza-4-azanidacyclopenta-2,5-diene-5-carboxamide
CAS Number: 111130-13-3
Molecular Formula: C₂₃H₂₅ClN₅NaO₅
Molecular Weight: 509.92
Catalog: Signaling Pathways GPCR/G Protein Leukotriene Receptor
Create Date: 2016-05-17 11:41:37
Modify Date: 2024-01-21 21:57:54
CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1].

Name	sodium,N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-2-methylphenyl]-1,2,3-triaza-4-azanidacyclopenta-2,5-diene-5-carboxamide
Synonyms	N-(5-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy)-4-chloro-2-methylphenyl)-1H-tetrazole-5-carboxamide monosodium salt N-(3-(3-(4-Acetyl-3-hydroxy-2-n-propylphenoxy)propoxy)-4-chloro-6-methylphenyl)-1H-tetrazole-5-carboxamide 1H-Tetrazole-5-carboxamide,N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy)-4-chloro-2-methylphenyl)-,monosodium salt

Description	CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Phospholipase Signaling Pathways >> GPCR/G Protein >> Leukotriene Receptor Research Areas >> Inflammation/Immunology
References	[1]. Beck A, et al. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.